Benowitz N - Search Results

1

Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.

Dermody SS, McClernon FJ, Benowitz N, Luo X, Tidey JW, Smith TT, Vandrey R, Hatsukami D, Donny EC. Dermody SS, et al. Among authors: benowitz n. Exp Clin Psychopharmacol. 2018 Jun;26(3):223-232. doi: 10.1037/pha0000179. Epub 2018 Mar 5. Exp Clin Psychopharmacol. 2018. PMID: 29504780 Free PMC article. Clinical Trial.

2

Nicotine elimination and tolerance in non-dependent cigarette smokers.

Shiffman S, Zettler-Segal M, Kassel J, Paty J, Benowitz NL, O'Brien G. Shiffman S, et al. Among authors: benowitz nl. Psychopharmacology (Berl). 1992;109(4):449-56. doi: 10.1007/BF02247722. Psychopharmacology (Berl). 1992. PMID: 1365861 Clinical Trial.

3

Pharmacokinetic considerations in understanding nicotine dependence.

Benowitz NL. Benowitz NL. Ciba Found Symp. 1990;152:186-200; discussion 200-9. doi: 10.1002/9780470513965.ch11. Ciba Found Symp. 1990. PMID: 2209254 Review.

4

Nicotine exposure among nondependent smokers.

Shiffman S, Fischer LB, Zettler-Segal M, Benowitz NL. Shiffman S, et al. Among authors: benowitz nl. Arch Gen Psychiatry. 1990 Apr;47(4):333-6. doi: 10.1001/archpsyc.1990.01810160033006. Arch Gen Psychiatry. 1990. PMID: 2322084

5

Effects of nicotine gum and tobacco smoking on human avoidance responding.

Cherek DR, Bennett RH, Kelly TH, Steinberg JL, Benowitz NL. Cherek DR, et al. Among authors: benowitz nl. Pharmacol Biochem Behav. 1989 Mar;32(3):677-81. doi: 10.1016/0091-3057(89)90017-8. Pharmacol Biochem Behav. 1989. PMID: 2740422

6

Society for Research on Nicotine and Tobacco.

Heishman SJ, Balfour DJ, Benowitz NL, Hatsukami DK, Lindstrom JM, Ockene JK. Heishman SJ, et al. Among authors: benowitz nl. Addiction. 1997 May;92(5):615-33. Addiction. 1997. PMID: 9219386

7

Effects of cotinine on information processing in nonsmokers.

Herzig KE, Callaway E, Halliday R, Naylor H, Benowitz NL. Herzig KE, et al. Among authors: benowitz nl. Psychopharmacology (Berl). 1998 Jan;135(2):127-32. doi: 10.1007/s002130050493. Psychopharmacology (Berl). 1998. PMID: 9497017 Free article.

8

Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy.

Jacob P 3rd, Hatsukami D, Severson H, Hall S, Yu L, Benowitz NL. Jacob P 3rd, et al. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1668-73. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496059 Clinical Trial.

9

Reducing tobacco harm: research challenges and issues.

Hatsukami DK, Slade J, Benowitz NL, Giovino GA, Gritz ER, Leischow S, Warner KE. Hatsukami DK, et al. Nicotine Tob Res. 2002;4 Suppl 2:S89-101. doi: 10.1080/1462220021000032852. Nicotine Tob Res. 2002. PMID: 12573171

10

Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies.

Hughes JR, Benowitz N, Hatsukami D, Mermelstein RJ, Shiffman S. Hughes JR, et al. Among authors: benowitz n. Nicotine Tob Res. 2004 Oct;6(5):863-4. doi: 10.1080/1462220042000282564. Nicotine Tob Res. 2004. PMID: 15700922 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

828 results

Search Page

Filters